Natixis Advisors, L.P. West Pharmaceutical Services Inc Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 53,747 shares of WST stock, worth $16.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

53,747

Previous 49,007 9.67%

Holding current value

$16.9 Million

Previous $16.1 Million 0.06%

% of portfolio

0.03%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$277.16 - $333.3 $1.31 Million - $1.58 Million	4,740 Added 9.67%	53,747 $16.1 Million
Q2 2024 Aug 01, 2024	SELL	$314.68 - $395.94 $1.86 Million - $2.34 Million	-5,904 Reduced 10.75%	49,007 $16.1 Million
Q1 2024 Apr 25, 2024	BUY	$338.27 - $413.0 $2.83 Million - $3.45 Million	8,353 Added 17.94%	54,911 $21.7 Million
Q4 2023 Feb 06, 2024	SELL	$318.29 - $392.21 $1.07 Million - $1.32 Million	-3,375 Reduced 6.76%	46,558 $16.4 Million
Q3 2023 Nov 13, 2023	BUY	$354.9 - $412.41 $2.11 Million - $2.46 Million	5,954 Added 13.54%	49,933 $18.7 Million
Q2 2023 Aug 15, 2023	BUY	$334.63 - $382.47 $216,505 - $247,458	647 Added 1.49%	43,979 $16.8 Million
Q1 2023 May 11, 2023	BUY	$232.5 - $346.47 $856,530 - $1.28 Million	3,684 Added 9.29%	43,332 $15 Million
Q4 2022 Jan 27, 2023	SELL	$209.34 - $261.61 $3.37 Million - $4.21 Million	-16,098 Reduced 28.88%	39,648 $9.33 Million
Q3 2022 Nov 14, 2022	BUY	$246.08 - $343.65 $235,990 - $329,560	959 Added 1.75%	55,746 $13.7 Million
Q2 2022 Aug 12, 2022	SELL	$280.61 - $420.45 $2.6 Million - $3.9 Million	-9,283 Reduced 14.49%	54,787 $16.6 Million
Q1 2022 May 12, 2022	BUY	$357.49 - $445.92 $875,135 - $1.09 Million	2,448 Added 3.97%	64,070 $26.3 Million
Q4 2021 Feb 08, 2022	BUY	$402.25 - $471.34 $2.62 Million - $3.07 Million	6,513 Added 11.82%	61,622 $28.9 Million
Q3 2021 Nov 15, 2021	SELL	$363.01 - $468.47 $1.88 Million - $2.43 Million	-5,182 Reduced 8.59%	55,109 $23.4 Million
Q2 2021 Aug 12, 2021	BUY	$284.77 - $363.2 $960,813 - $1.23 Million	3,374 Added 5.93%	60,291 $21.7 Million
Q1 2021 May 05, 2021	BUY	$257.29 - $307.53 $1.6 Million - $1.91 Million	6,217 Added 12.26%	56,917 $16 Million
Q4 2020 Feb 12, 2021	BUY	$261.16 - $301.66 $569,851 - $658,222	2,182 Added 4.5%	50,700 $14.4 Million
Q3 2020 Nov 12, 2020	SELL	$224.99 - $288.02 $715,018 - $915,327	-3,178 Reduced 6.15%	48,518 $13.3 Million
Q2 2020 Aug 11, 2020	BUY	$149.8 - $227.17 $1.92 Million - $2.91 Million	12,820 Added 32.98%	51,696 $11.7 Million
Q1 2020 Apr 27, 2020	BUY	$128.96 - $174.76 $2.88 Million - $3.9 Million	22,306 Added 134.62%	38,876 $5.92 Million
Q4 2019 Feb 10, 2020	BUY	$137.6 - $151.21 $188,649 - $207,308	1,371 Added 9.02%	16,570 $2.49 Million
Q3 2019 Nov 12, 2019	SELL	$121.41 - $150.02 $643,594 - $795,256	-5,301 Reduced 25.86%	15,199 $2.16 Million
Q2 2019 Aug 12, 2019	SELL	$111.27 - $125.15 $152,996 - $172,081	-1,375 Reduced 6.29%	20,500 $2.57 Million
Q1 2019 May 15, 2019	BUY	$94.53 - $110.2 $1.09 Million - $1.27 Million	11,485 Added 110.54%	21,875 $2.41 Million
Q4 2018 Feb 13, 2019	BUY	$93.0 - $123.98 $966,270 - $1.29 Million	10,390 New	10,390 $1.02 Million
Q1 2018 May 10, 2018	SELL	$85.56 - $102.4 $1.08 Million - $1.29 Million	-12,594 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$91.65 - $101.65 $68,645 - $76,135	749 Added 6.32%	12,594 $1.24 Million
Q3 2017 Nov 14, 2017	BUY	$84.54 - $96.75 $1 Million - $1.15 Million	11,845	11,845 $1.14 Million

Others Institutions Holding WST

# of Institutions

802

Shares Held

64.4M

Call Options Held

294K

Put Options Held

490K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $23.3B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. West Pharmaceutical Services Inc Transaction History